Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Stern

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
British Journal of Cancer|February 26, 2009
Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cellsS Agarwal, C Zerillo, J Kolmakova, et al.
Oncogene|May 3, 2006
Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4A J Jackson-Fisher, G Bellinger, E Shum, et al.
Oncogene|December 2, 2010
A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanomaS E Godshalk, T Paranjape, S Nallur, et al.
The Journal of Biological Chemistry|February 7, 1997
Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cellsS Kannan, M De Santis, M Lohmeyer, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
British Journal of Cancer|February 26, 2009
Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cellsS Agarwal, C Zerillo, J Kolmakova, et al.
Oncogene|May 3, 2006
Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4A J Jackson-Fisher, G Bellinger, E Shum, et al.
Oncogene|December 2, 2010
A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanomaS E Godshalk, T Paranjape, S Nallur, et al.
The Journal of Biological Chemistry|February 7, 1997
Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cellsS Kannan, M De Santis, M Lohmeyer, et al.
Pageof 7